Press Space to continue
Curated tech Twitter/X posts on AI, startups, and product development—signal without the doomscroll, updated on weekdays.
Press Space to continue
Press Space to continue
Thrive Capital’s Dr. Nworah Ayogu tested OpenAI’s reasoning models on New England Journal of Medicine’s “House M.D.-level” case studies: “OpenAI & o1 was batting 10 out of 10.” “These are cases that neither me nor my colleagues, who are some of the best doctors out there, maybe we would get it right 2 times out of 10.” @sama
NEW: Inside Thrive Capital w/ Partner Dr. Nworah Ayogu Investing in Neuralink, OpenAI, Isomorphic Labs, OpenEvidence, Oscar Health & the next trillion-dollar healthcare companies. @ThriveCapital manages $65B+ in AUM, having raised $10B+ for Thrive X earlier this year. Healthcare has been part of the firm's DNA since inception, with Josh Kushner incubating Oscar Health alongside Thrive itself. The firm has incubated ~10 healthcare companies, the majority valued at over $1B, including Oscar Health, Cedar, Rightway & Cadence. I sat down with Nworah (@nworahayogu), a Harvard-trained, board-certified physician & neuroscientist, former Amazon Clinic GM & Amazon Pharmacy's first Chief Medical Officer, to break down AI's next frontier in medicine. We cover: ›› Isomorphic Labs: Demis Hassabis, AI-designed drugs & the race to compress drug development from 10 years to 4 ›› Neuralink: $9B last funding valuation, brain implants, surgical robotics & restoring independence to patients with paralysis ›› OpenEvidence: $15B valuation, ~$300M annualized revenue & adoption by more than 65% of US physicians. Why AI could create 10X doctors ›› OpenAI: Why healthcare could become AI's most important use case, from clinical reasoning to personalized medicine Thrive's thesis: Building companies that are world-class in both technology & medicine, with investments spanning Chai Discovery, Formation Bio, Nudge, Fortell, Nourish & more “Because as a nation, I think we need a 10X nurse a lot more than we need a 10X engineer.” 𝐓𝐈𝐌𝐄𝐒𝐓𝐀𝐌𝐏𝐒 (00:00) Dr. Nworah Ayogu, Partner at Thrive Capital (01:52) The next AI trade is hiding in biotech (03:48) How AI designs a new drug (08:37) 9 out of 10 drugs fail, can AI flip that? (11:33) How Thrive got into Isomorphic Labs (14:14) Giving paralyzed veterans their hands back (20:39) Neuralink is more interesting than SpaceX (23:21) The hearing aid that broke the rating scale (30:18) The doctor who built Amazon Health (33:21) Why AGI makes healthcare the biggest bet (35:25) One cancer drug outearns every AI lab combined (37:55) How Lilly became healthcare's first $1T company (40:04) How Thrive helped OpenAI break into healthcare (44:13) OpenEvidence: 2/3 of US doctors in 3 years (46:16) Healthcare is 6x bigger than defense (48:15) $40T spent, zero gain in life expectancy (51:43) A custom gene therapy built for one baby (55:47) Saving Medicare $2.5M a week (1:04:13) Oscar's comeback from down 95% to up`1 100% (1:06:19) Why OpenAI is now a giant healthcare provider